0000-00-00 |
|
|
|
External link to document |
2020-07-30 |
1 |
Complaint |
United States Patent Nos. 7,601,740 (“the
’740 patent”), 10,449,185 (“the ’185 patent”), and 10,646,…the ’480 patent”) (collectively
“the patents-in-suit”). This action arises under the Patent Laws of the…Hetero has infringed the ’740 patent, the ’185 patent,
and the ’480 patent by submitting ANDA No. 214828…of the ’740 patent is attached as Exhibit A.
30. ACADIA owns the ’740 patent.
31…of the ’185 patent is attached as Exhibit B.
32. ACADIA owns the ’185 patent.
33 |
External link to document |
2020-10-05 |
14 |
Answer to Complaint |
owner of
U.S. Patent Nos. 7,601,740 (“the ʼ740 patent”), 10,449,185 (“the ʼ185 patent”), and 10,646,480… purports to be a copy of U.S. Patent No.
10,449,185 (the “ʼ185 patent”) is entitled “Formulations of… (Invalidity of U.S. Patent No. 10,449,185)
The claims of the patent-in-suit are invalid and… (Non-infringement of U.S. Patent No. 10,449,185)
The manufacture, use, sale, offer…Declaration of Non-Infringement of U.S. Patent No. 10,449,185)
29. Hetero USA repeats and |
External link to document |
2021-05-03 |
22 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,601,740; 10,449, 185; 10,646,480…July 2020
3 May 2021
1:20-cv-01022
835 Patent - Abbreviated New Drug Application(ANDA)
Defendant |
External link to document |
2020-07-30 |
4 |
Patent/Trademark Report to Commissioner of Patents |
Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,601,740 ;10,449,185 ;10,646,480. …July 2020
3 May 2021
1:20-cv-01022
835 Patent - Abbreviated New Drug Application(ANDA)
Defendant |
External link to document |